Sarah Derks - Concepedia

Author

Sarah Derks

Amsterdam University Medical Centers ORCID

Also Known As

Ahmet Demirkiran, Derks, Sarah, Penny, Robert, S Derks, S. Derks, Sarah Derks, T.C. Fleitas, Wouter L Curvers, Wouter L. Curvers, s Derks

188

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Amsterdam University Medical Centers Amsterdam UMC Location Vrije Universiteit Amsterdam Maastricht University Oncode Institute Cancer Center Amsterdam

About

Sarah Derks is an author at Amsterdam University Medical Centers specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	521
2	Immunology	3	3	472
3	Natural Sciences	1	1	39
4	Biostatistics	1	1	39
5	Cell Biology	1	1	27

Sarah Derks

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers Sarah Derks, Xiaoyun Liao, Anna Maria Chiaravalli, Oncotarget Lymphoid NeoplasiaCancer ImmunosurveillancePd-l1 ExpressionImmunologyTumor Immunity	2016	299
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma Eirini Pectasides, Matthew D. Stachler, Sarah Derks, Cancer Discovery	2017	293
Gain-of-Function <i>RHOA</i> Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer Haisheng Zhang, Antje Schaefer, Yichen Wang, Cancer Discovery	2019	165
Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas Sarah Derks, Leonie K. de Klerk, Xiaoshu Xu, Annals of Oncology Immune EvasionCancer ImmunosurveillanceEsophageal CancerTumor HeterogeneityImmunology	2020	146
Analysis of Promoter CpG Island Hypermethylation in Cancer: Location, Location, Location! Iris J.H. van Vlodrop, Hanneke E.C. Niessen, Sarah Derks, Clinical Cancer Research	2011	142
Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma Sarah Derks, Katie S. Nason, Xiaoyun Liao, Cancer Immunology Research	2015	139
Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group Sanne Nieuwenhuizen, Robbert S. Puijk, Bente A. T. van den Bemd, Cancers	2020	102
Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations Sarah Derks, Cindy Postma, Beatriz Carvalho, Carcinogenesis	2007	69
Promoter Methylation Precedes Chromosomal Alterations in Colorectal Cancer Development Sarah Derks, Cindy Postma, Peter T.M. Moerkerk, Analytical Cellular Pathology	2006	61
Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21 Sarah Derks, Linda J.W. Bosch, Hanneke E.C. Niessen, Carcinogenesis	2009	55

Page 1